More Company News

Scancell

Update on SCIB2 clinical development partnership
03 Feb 2021Read More

Scancell

Interim results for six months ended 31 October 2020
29 Jan 2021Read More

Scancell

COVID-19 vaccine candidate selected
18 Dec 2020Read More

Scancell

Appointment of CMO and Medical Director
17 Nov 2020Read More

Scancell

Result of adjourned General Meeting
05 Nov 2020Read More

Scancell

Conversion of CLNs and total voting rights
02 Nov 2020Read More

Scancell

Result of open offer and adjournment of General Meeting
29 Oct 2020Read More

Scancell

Conversion of CLNs
26 Oct 2020Read More

Scancell

Final results for year ended 30 April 2020
16 Oct 2020Read More

Scancell

Proposed investment by Redmile and Open Offer
12 Oct 2020Read More

1 2 3 4 5
Return to Scancell
© 2019-21 Trinity Delta. All rights reserved. Trinity Delta is regulated by the Financial Conduct Authority (Reference number: 725161).